Objectives

After participating in this educational activity, attendees should be able to:
1| Describe the pathogenesis of cystic fibrosis related diabetes (CFRD)
2| Identify other possible endocrine complications of CF
3| Summarize the impact of CFTR modulator therapy on CF and endocrine complications

 

Presenter(s): 
Michele Gortakowski, MD
Chief, Division of Pediatric Endocrinology, Department of Pediatrics, UMass Chan-Baystate
Assistant Professor of Medicine and Pediatrics, UMass Chan-Baystate

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Michele Gortakowski, MD SpeakerNo relevant relationships with ineligible companies to discloseNo

 

Session date: 
03/03/2026 - 12:00pm to 1:00pm EST
Location: 
Webinar
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 ACPE Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.